Winship Cancer Institute is a clinical research site located in Atlanta, Georgia, United States 30322.
Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
Winship Cancer Institute has participated in 88 clinical trials with 28 currently active.
Therapeutic areas: Carcinoma, Squamous Cell of Head and Neck, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV.
Sponsors: Celgene, EMD Serono Research & Development Institute, Inc., Gilead Sciences.
Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Winship Cancer Institute has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Winship Cancer Institute has 88 clinical trials on record, with 28 currently active. Their work covers Carcinoma, Squamous Cell of Head and Neck, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV.
Winship Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.